Company intelligence
Boston Children's Hospital
Where the world comes for answers.
About Boston Children's Hospital
Boston Children's Hospital is a 404-bed comprehensive center for pediatric health care. As one of the largest pediatric medical centers in the United States, Boston Children's offers a complete range of health care services for children from birth through 21 years of age. (Our services can begin interventions at 15 weeks gestation and in some situations we also treat adults.) We have approximately 25,000 inpatient admissions each year and our 200+ specialized clinical programs schedule 557,000 visits annually. Last year, the hospital performed more than 26,500 surgical procedures and 214,000 radiological examinations. Our team of physicians and nurses has been recognized by a number of independent organizations for overall excellence, and we're proud to share some notable examples with you here.
Verified activity
Signals from Boston Children's Hospital
12 published signals
Research & Knowledge
Boston Children's Hospital reported that AbbVie's Etentamig hit its phase 3 endpoints in multiple myeloma, showing improved response rates and a 60% reduction in progression risk.
Reported by Stefano Gianoli, PhD
Research & Knowledge
Boston Children's Hospital published new work in Cell from Paul Blainey's lab at the Broad, with MIT collaborators, solving a problem in molecular biology that constrained reading what a cell is doing.
Reported by Monica Jang, JD, CLP
Research & Knowledge
Boston Children's Hospital collaborated with Christopher Gazarian and Colleen Molinari MSN, RN, NPD-BC to develop and disseminate work on nursing professional development and automation.
Reported by Christopher Reeves, MSN, CNP, NPD-BC
Research & Knowledge
Boston Children's Hospital noted that a phase 2 mRNA cancer vaccine trial, BNT122-01, was halted by an independent DSMB due to a numerical imbalance in overall survival and a recommendation to stop the trial.
Reported by Stefano Gianoli, PhD
Research & Knowledge
Boston Children's Hospital noted that a companion trial pairing the same BNT122-01 vaccine with a checkpoint inhibitor in pancreatic cancer continues unaffected.
Reported by Stefano Gianoli, PhD
Presence & Recognition
Boston Children's Hospital published the first-author abstract Nimodipine Use in Pediatric Cerebral Vasospasm: Safety, Feasibility, and Outcomes from a Single Institution for presentation at the 2026 Neurocritical Care Society Annual Meeting in Seattle this October.
Reported by Dylan Keusch
Presence & Recognition
Boston Children's Hospital is engaging CNE, CNO, and CNIO colleagues nationally to provide feedback on ANA's draft position statement related to AI governance and practice through professional governance structures.
Reported by Laura J. Wood DNP, RN, NEA-BC, FAAN
Presence & Recognition
Boston Children's Hospital announced the presence of Enrique Gonzalez Saez-Diez and Xutong Xue at the Ebrahimi-Fakhari Laboratory.
Reported by Darius Ebrahimi-Fakhari
Legal & Regulatory
Boston Children's Hospital noted that Novartis paused eight autoimmune and neurology trials of its CD19 CAR-T rap-cel on August 24 after three deaths from immune effector cell-associated hemophagocytic syndrome (IEC-HS).
Reported by Stefano Gianoli, PhD
Research & Knowledge
Boston Children's Hospital is researching platelet transfusions in newborns
Reported by Boston Children's Hospital
Presence & Recognition
Boston Children's Hospital thanked Carly Keegan, Aisling Driscoll, and Geraldine Pierre for organizing an event.
Reported by Cass Mercer
People
Boston Children's Hospital is hiring a Senior Program Manager, Organizational Development to join the Talent Management team.
Reported by Jonathan Levene, MBA, PCC